Brian J. Lynch
2021 - Synta Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $240,610 |
|---|---|
| Option Awards | $2,731,200 |
| Salary | $445,333 |
| Other | $13,338 |
| Total | $3,430,481 |
Lynch received $2.7M in option awards, accounting for 80% of the total pay in 2021.
Lynch also received $240.6K in non-equity incentive plan, $445.3K in salary and $13.3K in other compensation.
Rankings
In 2021, Brian J. Lynch's compensation ranked 3,912th out of 12,406 executives tracked by ExecPay. In other words, Lynch earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,912 out of 12,406 | 69th |
Division Manufacturing | 1,599 out of 5,492 | 71st |
Major group Chemicals And Allied Products | 656 out of 2,368 | 72nd |
Industry group Drugs | 583 out of 2,089 | 72nd |
Industry Pharmaceutical Preparations | 407 out of 1,536 | 74th |
Pay ratio
| Brian J. Lynch's Pay | $3,430,481 |
|---|---|
| Median Employee's Pay | $459,419 |
| Pay Ratio | 7to 1 |
In 2021, the annual total compensation of Brian J. Lynch was $3,430,481.
The annual total compensation of the median employee at Synta Pharmaceuticals was $459,419.
The ratio of Brian J. Lynch's pay to the pay of median employee was therefore 7 to one.
Lynch's colleagues
We found five more compensation records of executives who worked with Brian J. Lynch at Synta Pharmaceuticals in 2021.
2021
Alex Howarth
Synta Pharmaceuticals
Chief Financial Officer
2021
Paul Friedman
Synta Pharmaceuticals
Chief Executive Officer
2021
Rebecca Taub
Synta Pharmaceuticals
Chief Medical Officer
2021
Marc Schneebaum
Synta Pharmaceuticals
Chief Financial Officer
2021
Remy Sukhija
Synta Pharmaceuticals